Jocelyn H Leu Selected Research

C-Reactive Protein

9/2014

Clinical efficacy, radiographic and safety findings through 5 years of subcutaneous golimumab treatment in patients with active psoriatic arthritis: results from a long-term extension of a randomised, placebo-controlled trial (the GO-REVEAL study).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jocelyn H Leu Research Topics

Disease

6	Rheumatoid Arthritis 01/2022 - 01/2016
5	Psoriatic Arthritis 01/2022 - 09/2014
4	Ankylosing Spondylitis 01/2022 - 01/2018
2	Opportunistic Infections (Opportunistic Infection) 01/2022 - 01/2020
2	Infections 01/2022 - 11/2017
2	Neoplasms (Cancer) 01/2022 - 01/2020
2	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 10/2021 - 01/2018
2	Necrosis 01/2018 - 02/2016
2	Psoriasis (Pustulosis Palmaris et Plantaris) 11/2017 - 09/2014
1	Tuberculosis (Tuberculoses) 01/2022
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 11/2020
1	Axial Spondyloarthritis 01/2019
1	Ulcerative Colitis 01/2019
1	Injection Site Reaction 01/2018

Drug/Important Bio-Agent (IBA)

14	golimumab FDA Link 01/2022 - 09/2014
3	Methotrexate (Mexate)FDA LinkGeneric 01/2022 - 01/2016
1	omega-Chloroacetophenone (Mace)IBA 01/2022
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022
1	Monoclonal AntibodiesIBA 01/2022
1	Insulin (Novolin)FDA Link 11/2020
1	Pharmaceutical PreparationsIBA 01/2019
1	Ustekinumab (CNTO 1275)FDA Link 01/2019
1	ametantrone (HAQ)IBA 11/2017
1	C-Reactive ProteinIBA 09/2014

Therapy/Procedure

3	Therapeutics 01/2022 - 02/2016
1	Injections 01/2018